Luis Paz-Ares and Federico Cappuzzo share their insights on optimal timing for IO treatment in resectable NSCLC and reflect on key data presented at WCLC and ESMO 2024.
Se-Hoon Lee and Tejas Patil explore how molecular testing guides treatment decisions with immunotherapy in locally advanced NSCLC by reviewing their own clinical case studies and the supporting clinical trial data.
Sandip Patel and Salma Jabbour discuss the importance of achieving pCR and the role of cfDNA in monitoring disease.
Luis Paz-Ares and Carlos Gil Ferreira review clinical approaches to treating unresectable and resectable NSCLC and highlight emerging data on the efficacy of chemo-IO induction therapy in locally advanced disease.